From previously published studies, FAP-specific CAR-T cells can kill most FAP+ cells, including CAFs, and prevent the growth of tumor stroma, which enhances the absorption of chemotherapy drugs and has anti-tumor benefits. The gene discussed is FAP; the disease is neoplasm.